Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chandler

Showing results (331-340 of 359) with videos related to

Pageof 36
Sort By:
Ejhaem|July 18, 2022
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVincent Ribrag, Julio C Chavez, Carola Boccomini, et al.
The Lancet. Haematology|February 25, 2021
Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trialJeff P Sharman, Danielle M Brander, Anthony R Mato, et al.
NPJ Breast Cancer|February 24, 2026
Transcriptomic analysis to uncover the mechanism of radiosensitization of AR-positive triple-negative breast cancers with AR inhibitionBreanna McBean, Benjamin Hauk, Anna R Michmerhuizen, et al.
Brain : a Journal of Neurology|October 26, 2020
A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS familiesCarolin K Scriba, Sarah J Beecroft, Joshua S Clayton, et al.
The Journal of Pathology|August 23, 2024
Single-cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney diseaseJennifer C Chandler, Daniyal J Jafree, Saif Malik, et al.
The Journal of Clinical Investigation|January 22, 2020
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombinationBenjamin C Chandler, Leah Moubadder, Cassandra L Ritter, et al.
Transboundary and Emerging Diseases|April 30, 2025
Landscape-Scale Epidemiological Dynamics of SARS-CoV-2 in White-Tailed DeerJoshua Hewitt, Grete Wilson-Henjum, Derek T Collins, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Positive Selection Screen for Natural Product β-Catenin InactivatorsMatthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Ecology and Evolution|June 13, 2025
Expanding National-Scale Wildlife Disease Surveillance Systems With Research NetworksKim M Pepin, Matthew A Combs, Guillaume Bastille-Rousseau, et al.
Cell|March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blastsAnna M Eiring, Jason G Harb, Paolo Neviani, et al.
Pageof 36

Showing results (331-340 of 359) with videos related to

Sort By:
Pageof 36
Ejhaem|July 18, 2022
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVincent Ribrag, Julio C Chavez, Carola Boccomini, et al.
The Lancet. Haematology|February 25, 2021
Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trialJeff P Sharman, Danielle M Brander, Anthony R Mato, et al.
NPJ Breast Cancer|February 24, 2026
Transcriptomic analysis to uncover the mechanism of radiosensitization of AR-positive triple-negative breast cancers with AR inhibitionBreanna McBean, Benjamin Hauk, Anna R Michmerhuizen, et al.
Brain : a Journal of Neurology|October 26, 2020
A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS familiesCarolin K Scriba, Sarah J Beecroft, Joshua S Clayton, et al.
The Journal of Pathology|August 23, 2024
Single-cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney diseaseJennifer C Chandler, Daniyal J Jafree, Saif Malik, et al.
The Journal of Clinical Investigation|January 22, 2020
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombinationBenjamin C Chandler, Leah Moubadder, Cassandra L Ritter, et al.
Transboundary and Emerging Diseases|April 30, 2025
Landscape-Scale Epidemiological Dynamics of SARS-CoV-2 in White-Tailed DeerJoshua Hewitt, Grete Wilson-Henjum, Derek T Collins, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Positive Selection Screen for Natural Product β-Catenin InactivatorsMatthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Ecology and Evolution|June 13, 2025
Expanding National-Scale Wildlife Disease Surveillance Systems With Research NetworksKim M Pepin, Matthew A Combs, Guillaume Bastille-Rousseau, et al.
Cell|March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blastsAnna M Eiring, Jason G Harb, Paolo Neviani, et al.
Pageof 36